title: Quality-of-life advantages of FK 506 vs conventional immunosuppressive drug therapy in cardiac transplantation.
authors.affiliation: Dept. of Psychiatry, University of Pittsburgh, PA 15213.
authors.forename: M A
authors.initials: MA
authors.lastname: Dew
authors.forename: R C
authors.initials: RC
authors.lastname: Harris
authors.forename: R G
authors.initials: RG
authors.lastname: Simmons
authors.forename: L H
authors.initials: LH
authors.lastname: Roth
authors.forename: J M
authors.initials: JM
authors.lastname: Armitage
authors.forename: B P
authors.initials: BP
authors.lastname: Griffith
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006304:Health Status; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology* / Q000523:psychology*; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D011241:Prednisone / Q000627:therapeutic use; D011788:Quality of Life; D016559:Tacrolimus / Q000627:therapeutic use*
chemical_list: D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone; D016559:Tacrolimus